Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Evaluation of Activity and Toxicity of Polychemotherapy With 2-drug Combinations Containing Gemcitabine as First Line Treatment of Elderly Patients With Small Cell Lung Cancer

Authors not listed

National Cancer Institute, Naples · 2000

Abstract

The purpose of this study is to describe the activity and toxicity of gemcitabine combined with four different drugs (carboplatin or cisplatin or etoposide or vinorelbine) as first line treatment of elderly patients with extensive small cell lung cancer.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-03 MST

Cite this

APA
Anonymous. (2000). Evaluation of Activity and Toxicity of Polychemotherapy With 2-drug Combinations Containing Gemcitabine as First Line Treatment of Elderly Patients With Small Cell Lung Cancer. <em>National Cancer Institute, Naples</em>. https://clinicaltrials.gov/study/NCT00401609
Vancouver
Anonymous. Evaluation of Activity and Toxicity of Polychemotherapy With 2-drug Combinations Containing Gemcitabine as First Line Treatment of Elderly Patients With Small Cell Lung Cancer. National Cancer Institute, Naples. 2000.
BibTeX
@misc{anon2000Evalua, title = {Evaluation of Activity and Toxicity of Polychemotherapy With 2-drug Combinations Containing Gemcitabine as First Line Treatment of Elderly Patients With Small Cell Lung Cancer}, author = {Anonymous}, journal = {National Cancer Institute, Naples}, year = {2000}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings